Tag: OpRegen
October 20, 2016
BioTime to Present OpRegen® Clinical Trial Data at ISOPT Clinical Symposium
BioTime, a clinical stage biotechnology company with a focus on pluripotent stem cell technologies, today reported that data from the... June 10, 2016